Fred Hutchinson Cancer Research Center Lung SPORE
Fred Hutchinson Cancer Research Center Lung SPORE
批准号:
10174865
负责人:
A McGarry Houghton
金额:
$186.35万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-08-01 至 2022-03-31
关键词:
AddressAntigensAtypical lymphocyteAutologousBenignBioinformaticsBiological MarkersBiometryCREBBP geneCancer EtiologyCancer PatientCell LineageCessation of lifeChromatinClinicalColoradoData SetDevelopmentDiagnosisDiagnosticDiagnostic radiologic examinationEvaluationFred Hutchinson Cancer Research CenterGenesGenetic DeterminismGenotypeGoalsGoldHistopathologyHybridsImage AnalysisImmune checkpoint inhibitorImmune responseImmunotherapyInfrastructureKDM1A geneLungLung CAT ScanLung noduleLymphocyteMalignant - descriptorMalignant neoplasm of lungMedicalMethodologyModelingMutationNeoplasm Circulating CellsNivolumabNon-Small-Cell Lung CarcinomaOncogenesOperative Surgical ProceduresPatient-Focused OutcomesPatientsPerformancePhase I Clinical TrialsPhase II Clinical TrialsPlasmaPrognosisProteinsResearchResearch DesignResearch PersonnelResearch Project GrantsResourcesSpecimenSurvival RateT cell therapyT-LymphocyteTestingTherapeuticTimeTranslational ResearchVaccinesX-Ray Computed Tomographyantigen testbasebench to bedsidecancer cellcancer immunotherapycareercheckpoint therapyclinical carecohortearly screeningeffective therapyhuman tissueimaging biomarkerimprovedindustry partnerinhibitor/antagonistinnovationlung cancer screeninglung small cell carcinomamouse modelneoantigensneutrophilnovelpatient derived xenograft modelpatient responseprogramsradiomicsreceptorresponserisk prediction modelrisk stratificationscreeningsuccesstherapeutic targettranslational cancer researchtreatment responsetumortumor microenvironment
中文摘要
项目摘要/摘要--总体
弗雷德·哈奇肺孢子包括四个创新项目,三个支持性核心,以及所需的
发展研究计划和职业提升计划。我们利用了以下优势
研究人员和我们的中心解决阻碍肺部有意义改善的三个关键障碍
癌症存活率:促进肺结节评估对肺癌的早期发现和
筛查,小细胞肺癌(SCLC)缺乏有效的治疗方法,以及
非小细胞肺癌(NSCLC)患者转向基于免疫的新疗法。为了克服这些障碍,
我们提出了以下四个方案:1)靶向中性粒细胞谱系以增强免疫检查点
抑制物在非小细胞肺癌中的作用,2)靶向新抗原用于肺癌免疫治疗,3)鉴定
小细胞肺癌对LSD1抑制敏感性的决定因素,以及4)肺结节的危险分层
使用血浆和成像生物标记物的CT成像检测。这些项目将由一个
管理核心,生物统计和生物信息学核心(BBC),以及组织病理学和生物显微镜
核心(HBC)。
英文摘要
Project Summary/Abstract – Overall
The Fred Hutch Lung SPORE consists of four innovative projects, three supportive cores, and the required
Developmental Research Program and Career Enhancement Program. We have leveraged the strengths of
the investigators and our Center to tackle three critical barriers precluding meaningful improvements in lung
cancer survival rates: facilitation of pulmonary nodule evaluation for lung cancer early detection and
screening, lack of effective therapies for small cell lung cancer (SCLC), and the sub-optimal response rates of
non-small cell lung cancer (NSCLC) patients to novel immune-based therapies. To overcome these barriers,
we propose the following four projects: 1) Targeting the Neutrophil Lineage to Enhance Immune Checkpoint
Inhibitor Efficacy in NSCLC, 2) Targeting Neoantigens for Lung Cancer Immunotherapy, 3) Identifying
Determinants of Sensitivity to LSD1 Inhibition in SCLC, and 4) Risk Stratification for Pulmonary Nodules
Detected by CT Imaging Using Plasma and Imaging Biomarkers. These projects will be supported by an
Administrative Core, a Biostatistics and Bioinformatics Core (BBC), and a Histopathology and Biospecimen
Core (HBC).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neutrophil derived proteinases abolish the IFNG signature in NSCLC
-
批准号:10717448
-
项目类别:
-
资助金额:$57.31万
-
财政年份:2023
-
负责人:A McGarry Houghton
-
依托单位:
Anxa2 drives the function of immune suppressive neutrophils in lung cancer
-
批准号:10310981
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2021
-
负责人:A McGarry Houghton
-
依托单位:
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
-
批准号:10301566
-
项目类别:
-
资助金额:$66.03万
-
财政年份:2021
-
负责人:A McGarry Houghton
-
依托单位:
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer Therapies
-
批准号:10700944
-
项目类别:
-
资助金额:$38.98万
-
财政年份:2021
-
负责人:A McGarry Houghton
-
依托单位:
Liquid biopsy of the lung to profile lung cancer
-
批准号:10053675
-
项目类别:
-
资助金额:$42.79万
-
财政年份:2020
-
负责人:A McGarry Houghton
-
依托单位:
Liquid biopsy of the lung to profile lung cancer
-
批准号:10259860
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2020
-
负责人:A McGarry Houghton
-
依托单位:
Liquid biopsy of the lung to profile lung cancer
-
批准号:10472743
-
项目类别:
-
资助金额:$38.97万
-
财政年份:2020
-
负责人:A McGarry Houghton
-
依托单位:
Liquid biopsy of the lung to profile lung cancer
-
批准号:10601449
-
项目类别:
-
资助金额:$14.31万
-
财政年份:2020
-
负责人:A McGarry Houghton
-
依托单位:
Administrative Core
-
批准号:10174875
-
项目类别:
-
资助金额:$17.39万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Project 1: Targeting the Neutrophil Lineage To Enhance Immune Checkpoint Inhibitor Efficacy in NSCLC
-
批准号:10174872
-
项目类别:
-
资助金额:$26.33万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Tumor-specific autoantibodies for SCLC early detection
-
批准号:10299616
-
项目类别:
-
资助金额:$14.89万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Developmental Research Program
-
批准号:10700903
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Administrative Core
-
批准号:10700915
-
项目类别:
-
资助金额:$22.85万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Administrative Core
-
批准号:10601298
-
项目类别:
-
资助金额:$5.45万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Tumor-specific autoantibodies for SCLC early detection
-
批准号:9912430
-
项目类别:
-
资助金额:$57.33万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Tumor-specific autoantibodies for SCLC early detection
-
批准号:10601432
-
项目类别:
-
资助金额:$27.38万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Fred Hutchinson Cancer Research Center Lung SPORE
-
批准号:10601288
-
项目类别:
-
资助金额:$58.18万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Project 1: Targeting the Neutrophil Lineage To Enhance Immune Checkpoint Inhibitor Efficacy in NSCLC
-
批准号:10700909
-
项目类别:
-
资助金额:$34.64万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Developmental Research Program
-
批准号:10601290
-
项目类别:
-
资助金额:$1.96万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
Developmental Research Program
-
批准号:10174868
-
项目类别:
-
资助金额:$6.22万
-
财政年份:2019
-
负责人:A McGarry Houghton
-
依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
-
批准号:2022J011295
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:王亚伟
-
依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
-
批准号:30801055
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2008
-
负责人:王丽梅
-
依托单位: